SCHEMBL5203259

SCHEMBL5203259

O=C(O)C1(C(=O)O)CC(O)C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.35
GRM4 Q14833 5/20 0.35
GRM6 O15303 3/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
GRM8 O00222 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALOX15 P16050 1/20 0.35
APLNR P35414 1/20 0.32
GRM2 Q14416 5/20 0.31
GRM3 Q14832 3/20 0.31
GRM1 Q13255 2/20 0.31
GRM5 P41594 1/20 0.31
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29280475 0.97 GRM4 (0.33) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL27620337 0.97 GRM4 (0.33) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL27601761 0.97 GRM4 (0.33) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL29280477 0.97 GRM4 (0.33) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL6686381 0.75 CYP2C19 (0.35) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL4291628 0.73 SMN1; SMN2 (0.35) ALDH1A1MEN1KMT2AKDM4EALOX15
SCHEMBL27788454 0.73 GRM4 (0.35) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL25475447 0.73
SCHEMBL15876350 0.73 GRM4 (0.33) CYP2C19GRM4GRM6ALDH1A1CYP1A2
SCHEMBL6105605 0.73 GRM4 (0.35) CYP2C19GRM4GRM6ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106565859-B Cyclodextrin-bonded object of a kind of chirality platinum-and its preparation method and application 昆明理工大学 2019-09-27 CN claimed
CN-103145762-B Divalence platinum complex containing aryl steric group, preparation method and application thereof SOUTHEAST UNIVERSITY (CN) 2016-03-02 CN claimed
CN-103224533-B Alkyl carboxylic acid root containing nitric ether group is anti-tumor platinum (II) title complex of part SOUTHEAST UNIVERSITY (CN) 2015-10-07 CN claimed
CN-102234295-B Platinum (II) complex adopting N-alkyl substituted trans 1,2-diaminocyclohexane as ligand and preparation method thereof UNIV SOUTHEAST 2014-01-08 CN claimed
CN-102260294-B Binuclear platinum (II) complex or platinum (II) complex and application thereof UNIV SOUTHEAST 2013-09-18 CN claimed
CN-103224533-A Antitumor platinum (II) complex by taking alkyl carboxylate radical as ligand UNIV SOUTHEAST 2013-07-31 CN claimed
CN-103145762-A Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof UNIV SOUTHEAST 2013-06-12 CN claimed
CN-102260294-A Binuclear platinum (II) complex or platinum (II) complex and application thereof 2011-11-30 CN claimed
CN-102234295-A Platinum (II) complex adopting N-alkyl substituted trans 1,2-diaminocyclohexane as ligand and preparation method thereof UNIV SOUTHEAST 2011-11-09 CN claimed
EP-1603930-B1 PROTEIN-BOUND DERIVATIVES OF PLATINUM COMPLEXES CONTAINING CYCLOBUTANE 1.1-DICARBOXYLLATE LIGANDS KTB TUMORFORSCHUNGS GMBH (DE) 2007-08-29 EP claimed
CN-106543234-B Using saturated chain as chiral binuclear platinum complex of bridge and its preparation method and application 昆明理工大学 2019-04-09 CN disclosed
CN-104610415-B Liver target platinum-containing anticancer drug and synthetic method thereof KUNMING INSTITUTE OF PRECIOUS METALS (CN) 2016-05-25 CN disclosed
CN-103145762-B Divalence platinum complex containing aryl steric group, preparation method and application thereof SOUTHEAST UNIVERSITY (CN) 2016-03-02 CN disclosed
CN-103145762-B Divalence platinum complex containing aryl steric group, preparation method and application thereof SOUTHEAST UNIVERSITY (CN) 2016-03-02 CN disclosed
CN-103764653-B As compound and the composition of c-Kit kinase inhibitor IRM LLC (BM) 2015-12-02 CN disclosed
US-7452901-B2 Anti-cancer phosphonate analogs GILEAD SCIENCES, INC. (US) 2008-11-18 US disclosed
US-7452901-B2 Anti-cancer phosphonate analogs GILEAD SCIENCES, INC. (US) 2008-11-18 US disclosed
CN-1821253-A Novel water soluble Pt (II) anti-cancer ligand and its preparing method GUIYAN PHARMACEUTICAL CO LTD K (CN) 2006-08-23 CN disclosed
CN-1634946-A Platinum complex for treating cancer and method for making same INST OF PRECIOUS METALS KUNMIN (CN) 2005-07-06 CN disclosed
WO-2004099224-A1 CARBOPLATIN-TYPE PLATINUM (II) COMPLEXES UNIVERSITÄT REGENSBURG (DE) 2004-11-18 WO disclosed